202 related articles for article (PubMed ID: 1328770)
1. Most peripheral, node-negative, non-small-cell lung cancers have low proliferative rates and no intratumoral and peritumoral blood and lymphatic vessel invasion. Rationale for treatment with wedge resection alone.
Macchiarini P; Fontanini G; Hardin JM; Pingitore R; Angeletti CA
J Thorac Cardiovasc Surg; 1992 Oct; 104(4):892-9. PubMed ID: 1328770
[TBL] [Abstract][Full Text] [Related]
2. Blood vessel invasion by tumor cells predicts recurrence in completely resected T1 N0 M0 non-small-cell lung cancer.
Macchiarini P; Fontanini G; Hardin MJ; Chuanchieh H; Bigini D; Vignati S; Pingitore R; Angeletti CA
J Thorac Cardiovasc Surg; 1993 Jul; 106(1):80-9. PubMed ID: 8391612
[TBL] [Abstract][Full Text] [Related]
3. Invasion of blood vessels as significant prognostic factor in radically resected T1-3N0M0 non-small-cell lung cancer.
Gabor S; Renner H; Popper H; Anegg U; Sankin O; Matzi V; Lindenmann J; Smolle Jüttner FM
Eur J Cardiothorac Surg; 2004 Mar; 25(3):439-42. PubMed ID: 15019675
[TBL] [Abstract][Full Text] [Related]
4. Blood vessel invasion is a major prognostic factor in resected non-small cell lung cancer.
Kessler R; Gasser B; Massard G; Roeslin N; Meyer P; Wihlm JM; Morand G
Ann Thorac Surg; 1996 Nov; 62(5):1489-93. PubMed ID: 8893589
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of intratumoral blood vessel invasion in pathologic stage IA non-small cell lung cancer.
Shoji F; Haro A; Yoshida T; Ito K; Morodomi Y; Yano T; Maehara Y
Ann Thorac Surg; 2010 Mar; 89(3):864-9. PubMed ID: 20172144
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.
Hung JJ; Wang CY; Huang MH; Huang BS; Hsu WH; Wu YC
J Thorac Cardiovasc Surg; 2007 Sep; 134(3):638-43. PubMed ID: 17723811
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer.
Miyoshi K; Moriyama S; Kunitomo T; Nawa S
J Thorac Cardiovasc Surg; 2009 Feb; 137(2):429-34. PubMed ID: 19185165
[TBL] [Abstract][Full Text] [Related]
8. Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer.
Shimizu K; Yoshida J; Nagai K; Nishimura M; Ishii G; Morishita Y; Nishiwaki Y
J Thorac Cardiovasc Surg; 2005 Jul; 130(1):160-5. PubMed ID: 15999057
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimension.
Okada M; Sakamoto T; Nishio W; Uchino K; Tsubota N
Cancer; 2003 Aug; 98(3):535-41. PubMed ID: 12879471
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (stage IIIA-N2). Impact of adjuvant therapies in a subset of patients at high risk of recurrence.
Angeletti CA; Lucchi M; Fontanini G; Mussi A; Chella A; Ribechini A; Vignati S; Bevilacqua G
Cancer; 1996 Aug; 78(3):409-15. PubMed ID: 8697384
[TBL] [Abstract][Full Text] [Related]
11. Nonanatomic prognostic factors in resected nonsmall cell lung carcinoma: the importance of perineural invasion as a new prognostic marker.
Sayar A; Turna A; Solak O; Kiliçgün A; Urer N; Gürses A
Ann Thorac Surg; 2004 Feb; 77(2):421-5. PubMed ID: 14759409
[TBL] [Abstract][Full Text] [Related]
12. Very important histopathological factors in patients with resected non-small cell lung cancer: necrosis and perineural invasion.
Kiliçgün A; Turna A; Sayar A; Solak O; Urer N; Gürses A
Thorac Cardiovasc Surg; 2010 Mar; 58(2):93-7. PubMed ID: 20333571
[TBL] [Abstract][Full Text] [Related]
13. Lymph node isolated tumor cells and micrometastases in pathological stage I non-small cell lung cancer: prognostic significance.
Rena O; Carsana L; Cristina S; Papalia E; Massera F; Errico L; Bozzola C; Casadio C
Eur J Cardiothorac Surg; 2007 Dec; 32(6):863-7. PubMed ID: 17936004
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement.
Inoue M; Minami M; Shiono H; Sawabata N; Ideguchi K; Okumura M
J Thorac Cardiovasc Surg; 2006 May; 131(5):988-93. PubMed ID: 16678580
[TBL] [Abstract][Full Text] [Related]
15. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease.
Hsu CP; Hsia JY; Chang GC; Chuang CY; Shai SE; Yang SS; Lee MC; Kwan PC
J Thorac Cardiovasc Surg; 2009 Aug; 138(2):426-33. PubMed ID: 19619791
[TBL] [Abstract][Full Text] [Related]
16. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value and therapeutic consequences of vascular invasion in non-small cell lung carcinoma.
Bodendorf MO; Haas V; Laberke HG; Blumenstock G; Wex P; Graeter T
Lung Cancer; 2009 Apr; 64(1):71-8. PubMed ID: 18790545
[TBL] [Abstract][Full Text] [Related]
18. T2 tumors larger than five centimeters in diameter can be upgraded to T3 in non-small cell lung cancer.
Carbone E; Asamura H; Takei H; Kondo H; Suzuki K; Miyaoka E; Tsuchiya R; Motta G
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):907-12. PubMed ID: 11689795
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological study of p-T1aN0M0 non-small-cell lung cancer, as defined in the seventh edition of the TNM classification of malignant tumors.
Igai H; Matsuura N; Tarumi S; Chang SS; Misaki N; Go T; Ishikawa S; Yokomise H
Eur J Cardiothorac Surg; 2011 Jun; 39(6):963-7. PubMed ID: 20951601
[TBL] [Abstract][Full Text] [Related]
20. Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma. Correlation with TNM stage and disease free and overall survival.
Bréchot JM; Chevret S; Charpentier MC; Appere de Vecchi C; Capron F; Prudent J; Rochemaure J; Chastang C
Cancer; 1996 Nov; 78(10):2111-8. PubMed ID: 8918404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
